TAC1 and migraine disorder: For example, findings reported in 2016 evaluated the changes in vasoactive substances CGRP, 5-HT, NO, and substance P in migraine patients before and after the percutaneous occlusion of PFO, suggesting that migraine symptoms of patients were significantly improved, and the contents of four vasoactive substances in peripheral blood were reduced after closure [44].